METASTATIC OVARIAN CANCER
Clinical trials for METASTATIC OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC OVARIAN CANCER trials appear
Sign up with your email to follow new studies for METASTATIC OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharging your own immune cells to fight Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental treatment for people with metastatic cancers (colorectal, pancreatic, ovarian, breast, and neuroendocrine tumors) that have not responded to standard therapy. Doctors take white blood cells from a patient's tumor, grow the most cancer-fighting one…
Matched conditions: METASTATIC OVARIAN CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:26 UTC
-
New hope for advanced cancers: first human trial of ERX-315 begins
Disease control Recruiting nowThis early-stage study tests a new drug called ERX-315 in people with advanced solid tumors (like breast, ovarian, or pancreatic cancer) that no longer respond to standard treatments. The main goal is to check the drug's safety and find the best dose for future studies. About 15 …
Matched conditions: METASTATIC OVARIAN CANCER
Phase: PHASE1 • Sponsor: EtiraRx Australia Pty Ltd • Aim: Disease control
Last updated May 18, 2026 12:03 UTC